Results 51 to 60 of about 994,937 (217)
Defibrillation thresholds testing of implantable cardioverter-defibrillators at implantation
Journal of the American College of Cardiology, 2005 I read with interest the reports on defibrillation testing (DFT) during implantable cardioverter-defibrillator (ICD) implantation published recently in JACC ([1,2][1]). There is a significant, albeit low, risk to serious complications including death during DFT testing.
openaire +2 more sources
Defibrillation Testing During Defibrillator Implantation [PDF]
Arrhythmia & Electrophysiology Review, 2012 Implantable cardioverter defibrillators (ICDs) terminate ventricular tachycardia (VT) and ventricular fibrillation (VF) with high efficacy. ICDs improve mortality in patients after survived sudden cardiac death (SCD) and in patients at high risk of dying suddenly.
openaire +3 more sources
Patient preferences for deactivation of implantable cardioverter-defibrillators.
JAMA Internal Medicine, 2013 While implantable cardioverter defibrillators (ICDs) prolong life, painful shocks can occur at the end of life, and physicians rarely discuss the option of device deactivation 1,2.
J. Dodson +4 more
semanticscholar +1 more source
Model-based Pre-clinical Trials for Medical Devices Using Statistical Model Checking [PDF]
arXiv, 2021 Clinical trials are considered as the golden standard for medical device validation. However, many sacrifices have to be made during the design and conduction of the trials due to cost considerations and partial information, which may compromise the significance of the trial results. In this paper, we proposed a model-based pre-clinical trial framework
arxiv
Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators? [PDF]
Circulation: Arrhythmia and Electrophysiology, 2014 Because the implantable cardioverter defibrillator (ICD) was introduced into clinical practice, insertion of these devices has typically involved defibrillation testing (DT). However, DT has never been shown to independently improve patient outcomes. The rationale for DT has always been that the induction of ventricular fibrillation (VF) immediately ...
Jeff S. Healey, Michela Brambatti
openaire +3 more sources
Sex difference in clinical outcome of patients with implantable cardioverter-defibrillator
Research in Cardiovascular Medicine, 2013 Background: Indications for the use of the Implantable Cardioverter-Defibrillator (ICD) have been greatly expanded in recent years, but the influence of sex on the efficacy of the ICD in eligible patients has still been remained unknown.
Neshat Nazari +4 more
doaj +1 more source
TinyML Design Contest for Life-Threatening Ventricular Arrhythmia Detection [PDF]
arXiv, 2023 The first ACM/IEEE TinyML Design Contest (TDC) held at the 41st International Conference on Computer-Aided Design (ICCAD) in 2022 is a challenging, multi-month, research and development competition. TDC'22 focuses on real-world medical problems that require the innovation and implementation of artificial intelligence/machine learning (AI/ML) algorithms
arxiv
Slovenian Journal of Public Health, 2018 The purpose of this study is to analyse and present the causes of the differences in crude utilization rate in cardiac implantation electronic devices, specifically pacemakers and automatic implantable cardioverter-defibrillators, across 5 European ...
Prevolnik Rupel Valentina +2 more
doaj +1 more source
Role of artificial intelligence in defibrillators: a narrative review
Open Heart, 2022 Automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs) are used to treat life-threatening arrhythmias. AEDs and ICDs use shock advice algorithms to classify ECG tracings as shockable or non-shockable rhythms in ...
Mahmood Ahmad +10 more
doaj +1 more source
Real-World Data Analysis of Implantable Cardioverter Defibrillator (ICD) in Patients with Hypertrophic Cardiomyopathy (HCM) [PDF]
arXiv, 2020 Background: One of the common causes of sudden cardiac death (SCD) in young people is hypertrophic cardiomyopathy (HCM) and the primary prevention of SCD is with an implantable cardioverter defibrillators (ICD). Concerning the incidence of appropriate ICD therapy and the complications associated with ICD implantation and discharge, patients with ...
arxiv